FDA issued a Warning Letter to Jazz Pharmaceuticals, Inc on 10/11/2011 as a result of this inspection.
483 Jazz Pharmaceuticals May 2011
483 Jazz Pharmaceuticals May 2011Daniel Roberts FDA$119.00 - Available Now
FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 06 May 2011.
Add To Cart
- Category: Human Drugs
- Number of Observations: 3
- Inspection end: 06 May 2011
- Location: Palo Alto, United States
- FEI: 3005615655